Data, Outcomes, and Quality (DOQ)
DOQ Home
Surveys and Data Collection Systems >>
Behavioral Health Prevalence Data (NSDUH)
Emergency Room Data (DAWN)
Facilities Data (N-SSATS)
Treatment Data (TEDS)
Publications >>
Single-Topic Short Reports
Data Spotlights
Topical, Multi-Survey Data Reviews
Methodology Reports
Topical Analytical Reports
State and Metro Reports
Other Mental Health Statistics Reports
Data Access >>
Public-Use Data Files (SAMHDA)
Request Data
Links >>
Reports by Topic
FAQ
Evidence-Based Programs (NREPP)
- View Reports By Topic >>
- A-B »
-
A Adderall®AdolescentsADHD Stimulant MedicationsADSS (Alcohol & Drug Services Study)AdultsAdverse ReactionsAlcoholAlcohol dependenceAlcohol problemsAlcohol treatmentAmphetaminesAnalgesicsB BenzodiazepinesBinge drinkingBuprenorphine
-
- C
»
-
C Children and familiesChurch/Faith-based activitiesCigarettes, Cigars (see tobacco)Cities / urban areasCocaine/crack cocaineComorbidity/Co-occurring disordersCosts of treatmentCough medicineCriminal justice system
-
- D »
-
D DASIS (Drug Abuse Services Information System)DAWN (Drug Abuse Warning Network)DepressionDetox/DetoxificationDextromethorphan® Driving under the Influence; Driving While Intoxicated (DUI/DWI)Drug Services Research Survey (DSRS)DrugsDrug DependenceDrug ProblemsDrug TreatmentDrug brand / generic namesDrug names: PronunciationDrug Services Research SurveyDSRS (Drug Services Research Survey)DUI/DWI
-
- E-H »
-
E Ecstasy (MDMA)Elderly/Older adultsEmergency Department visitsF FemalesFlunitrazapam (see sedatives)G GenderGHB (Gamma Hydroxy Butyrate)Generic/brand drug namesH HallucinogensHashish(see Marijuana)Health insuranceHeavy drinkingHeroinHydrocodone(see analgesics)
-
- I-L »
-
I InhalantsInhalation drug useInpatient treatmentInjection drug useInsuranceJ
K KetamineL LAAMLicensing regulations and drinkingLSD
-
- M-N »
-
M Marijuana/hashishMDMA (Ecstasy)Mental healthMethadoneMethamphetamineN NicotineNonmedical use of prescription drugsNon response reportNSDUH/NHSDAN-SSATS
-
- O-Q »
-
O Older AdultsOpiatesOutpatient treatmentOver-the-Counter drugsOxycodoneOxycontin®P Pain relieversPCPPerceived RiskPeyotePregnant/recent mothersPrescription drugsQ
-
- R »
-
R Racial & ethnic groups:African AmericansAlaskan NativesAmerican IndiansAsiansBlacksHispanicsLatinas/LatinosPacific IslandersWhites/CaucasiansRegionsResidential treatmentRitalin®Rohypnol ®Rural/urban areas
-
- S »
-
S Salvia divinorum(see hallucinogens)SedativesSpecial studiesSpecific drugsSpeed/AmphetamineSROS (Services Research Outcome Study)State dataStimulantsSubstance UseSub State dataSuicideSupport
-
- T-Z »
-
T TEDS Tobacco (Cigarettes, cigars, smokeless tobacco)TranquilizersTreatment LocatorU Urban/rural areasV VeteransViolenceW WomenX XTC(see Ecstasy/MDMA)Y Young Adults (18-25 years of age)Youth (under 17 years of age)Z
-
- A-B »
Search Reports:
About DOQ
The purpose of Strategic Initiative #7 is to realize an integrated data strategy and a national framework for quality improvement in behavioral health care that will inform policy, measure program impact, and lead to improved quality of services and outcomes for individuals, families, and communities